Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

NCT05690048 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Immunotherapy
HCC - Hepatocellular Carcinoma

Interventions

DRUG: Fecal microbiota transfer
DRUG: Vancomycin Oral Capsule
DRUG: Atezolizumab + Bevacizumab
DRUG: Placebo Vancomycin Oral Capsule
DRUG: Placebo Fecal microbiota transfer

Sponsor

Michael Dill

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]